3 Stocks Estimated To Be Trading Up To 44.8% Below Intrinsic Value

The United States market has shown robust performance, climbing 1.2% in the last week and 29% over the past year, with earnings projected to grow by 17% annually. In such an environment, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking potential growth at a reasonable price.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name Current Price Fair Value (Est) Discount (Est) Upstart Holdings (UPST) $28.56 $56.20 49.2% Tenable Holdings (TENB) $25.45 $48.32 47.3% Super Group (SGHC) (SGHC) $13.51 $26.84 49.7% Rayonier (RYN) $20.36 $40.08 49.2% Live Oak Bancshares (LOB) $37.28 $74.21 49.8% Kingstone Companies (KINS) $15.92 $31.31 49.1% Gilead Sciences (GILD) $134.36 $268.60 50% FB Financial (FBK) $52.68 $101.61 48.2% Coastal Financial (CCB) $69.66 $134.79 48.3% AbbVie (ABBV) $215.70 $420.46 48.7%

Click here to see the full list of 145 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Let's review some notable picks from our screened stocks.

Sotera Health

Overview: Sotera Health Company offers sterilization solutions, lab testing, and advisory services to the healthcare industry globally, with a market cap of approximately $4.47 billion.

Operations: Sotera Health generates revenue through its segments: Nordion ($197.07 million), Nelson Labs ($219.84 million), and Sterigenics ($772.23 million).

Estimated Discount To Fair Value: 20.6%

Sotera Health is trading at US$15.66, below its estimated future cash flow value of US$19.73, indicating potential undervaluation based on cash flows. Earnings are expected to grow significantly at 29% annually over the next three years, outpacing the broader US market. However, interest payments remain a concern as they are not well covered by earnings despite recent refinancing efforts that reduced interest rate spreads slightly through new term loans totaling approximately US$1.42 billion.

The analysis detailed in our Sotera Health growth report hints at robust future financial performance. Take a closer look at Sotera Health's balance sheet health here in our report.SHC Discounted Cash Flow as at May 2026

Allison Transmission Holdings

Overview: Allison Transmission Holdings, Inc. designs, manufactures, and sells fully automatic transmissions for medium- and heavy-duty commercial and tactical vehicles, with a market cap of approximately $9.11 billion.

Operations: The company's revenue segments include the design, manufacturing, and sale of fully automatic transmissions for medium- and heavy-duty commercial vehicles as well as medium- and heavy-tactical vehicles.

Estimated Discount To Fair Value: 44.8%

Story Continues

Allison Transmission Holdings is trading at US$109.87, significantly below its estimated future cash flow value of US$198.91, suggesting it is undervalued based on cash flows. While earnings are forecast to grow 17% annually, outpacing the broader US market, debt coverage by operating cash flow remains a concern. Recent earnings showed sales of US$1.41 billion but declining net income and profit margins compared to the previous year highlight potential operational challenges despite promising revenue growth forecasts.

Our growth report here indicates Allison Transmission Holdings may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in Allison Transmission Holdings' balance sheet health report.ALSN Discounted Cash Flow as at May 2026

Glacier Bancorp

Overview: Glacier Bancorp, Inc. is a bank holding company for Glacier Bank, offering commercial banking services to individuals, small to medium-sized businesses, community organizations, and public entities in the United States with a market cap of approximately $6.20 billion.

Operations: The company generates revenue of $1.04 billion from its banking services, catering to a diverse clientele including individuals, businesses, community organizations, and public entities in the United States.

Estimated Discount To Fair Value: 24.4%

Glacier Bancorp is trading at US$47.66, below its estimated future cash flow value of US$63.02, indicating it is undervalued based on cash flows. Earnings are expected to grow significantly at 30.7% annually, surpassing the broader US market growth rate of 16.8%. Recent earnings showed net interest income rose to US$268.68 million from US$189.98 million a year ago, though increased net charge-offs present some risk factors for investors to consider.

According our earnings growth report, there's an indication that Glacier Bancorp might be ready to expand. Dive into the specifics of Glacier Bancorp here with our thorough financial health report.GBCI Discounted Cash Flow as at May 2026

Make It Happen

Embark on your investment journey to our 145 Undervalued US Stocks Based On Cash Flows selection here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Ready For A Different Approach?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SHCALSN and GBCI.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments